Journal article
Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury
M Cai, ZM Huttinger, H He, W Zhang, F Li, LA Goodman, DG Wheeler, LJ Druhan, JL Zweier, KM Dwyer, G He, AJF d'Apice, SC Robson, PJ Cowan, RJ Gumina
Journal of Molecular and Cellular Cardiology | ELSEVIER SCI LTD | Published : 2011
Abstract
Modulation of purinergic signaling is critical to myocardial homeostasis. Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD-1; CD39) which converts the proinflammatory molecules ATP or ADP to AMP is a key regulator of purinergic modulation. However, the salutary effects of transgenic over expression of ENTPD-1 on myocardial response to ischemic injury have not been tested to date. Therefore we hypothesized that ENTPD-1 over expression affords myocardial protection from ischemia-reperfusion injury via specific cell signaling pathways. ENTPD-1 transgenic mice, which over express human ENTPDase-1, and wild-type (WT) littermates were subjected to either ex vivo or in vivo ischemia-reperfus..
View full abstractGrants
Awarded by National Institutes of Health
Funding Acknowledgements
This work was supported by National Institutes of Health, National Heart, Lung, and Blood Institute Grants K08-HL094703 and R21-HL096038, an American Heart Association-Great Rivers Affiliate Student Undergraduate Research Fellowship Grant 10UFEL4180090 (ZMH, HH and LAG), the Davis Heart and Lung Research Institute and Ross Academic Advisory Committee (RJG).